SEC Form 4 · accession 0001209191-17-031417
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G Grey
Director
Period of report
May 10, 2017
Accepted (ET)
May 10, 2017 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 10, 2017 | P | 10,000 | $9.48 | A | 25,448 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.